Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-market Clinical Follow-up Study to Confirm Safety, Performance and Clinical Benefits Data of the NexGen® Trabecular Metal™ (TM) Augmentation Patella (Implants and Instrumentation)- A Retrospective and Prospective Consecutive Series Study

NCT05253976 is registered in ClinicalTrials.gov with Zimmer Biomet as lead sponsor.

NCT NCT05253976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05253976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-market Clinical Follow-up Study to Confirm Safety, Performance and Clinical Benefits Data of the NexGen® Trabecular Metal™ (TM) Augmentation Patella (Implants and Instrumentation)- A Retrospective and Prospective Consecutive Series Study
Lead sponsor
Zimmer Biomet
Phase
Observational
Overall status
Withdrawn
Start date
September 30, 2022
Completion date
December 31, 2034
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

functional deformity, non-inflammatory degenerative joint disease, revision total knee arthroplasty, rheumatoid arthritis